BIOMAT Database Logo BIOMAT Database Logo

Decreased fertility in male rats administered the 5 alpha-reductase inhibitor, finasteride, is due to deficits in copulatory plug formation. 1991

M A Cukierski, and J L Sina, and S Prahalada, and L D Wise, and J M Antonello, and J S MacDonald, and R T Robertson
Department of Safety Assessment, Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.

Oral administration of 80 mg/kg/day of finasteride, a potent specific inhibitor of 5 alpha-reductase, to sexually mature male Sprague-Dawley rats for 24 to 38 weeks caused an approximate 30% to 40% decrease in fertility. There were no effects on mating indices or implants per pregnant female. From the mating trials, a selected group of treated males with poor reproductive performance was compared to a selected group of control males with good reproductive performance. Observed matings showed no qualitative effects on mating behavior or ejaculation. However, finasteride-treated males did not form or formed small and improperly positioned copulatory plugs, which are required in rats to transport sperm into the uterus. Intrauterine insemination of epididymal sperm from males that were nonfertile by natural mating resulted in similar numbers of embryos and unfertilized oocytes recovered from controls and finasteride-treated males, confirming that there was no effect of finasteride on the ability of sperm to fertilize. Decreased fertility of finasteride-treated males was due to failure to form copulatory plugs and is related to decreased weight of seminal vesicles and prostate, an expected pharmacologic effect. Testes weight was unaffected. Decreased fertility in male rats after finasteride administration is considered a species specific effect. The mechanism of the decrease in rats is not likely to be relevant to species that do not form copulatory plugs.

UI MeSH Term Description Entries
D008297 Male Males
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D012098 Reproduction The total process by which organisms produce offspring. (Stedman, 25th ed) Human Reproductive Index,Human Reproductive Indexes,Reproductive Period,Human Reproductive Indices,Index, Human Reproductive,Indexes, Human Reproductive,Indices, Human Reproductive,Period, Reproductive,Periods, Reproductive,Reproductive Index, Human,Reproductive Indices, Human,Reproductive Periods
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D003307 Copulation Sexual union of a male and a female in non-human species. Copulations
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004622 Embryo, Mammalian The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS. Embryonic Structures, Mammalian,Mammalian Embryo,Mammalian Embryo Structures,Mammalian Embryonic Structures,Embryo Structure, Mammalian,Embryo Structures, Mammalian,Embryonic Structure, Mammalian,Embryos, Mammalian,Mammalian Embryo Structure,Mammalian Embryonic Structure,Mammalian Embryos,Structure, Mammalian Embryo,Structure, Mammalian Embryonic,Structures, Mammalian Embryo,Structures, Mammalian Embryonic
D004822 Epididymis The convoluted cordlike structure attached to the posterior of the TESTIS. Epididymis consists of the head (caput), the body (corpus), and the tail (cauda). A network of ducts leaving the testis joins into a common epididymal tubule proper which provides the transport, storage, and maturation of SPERMATOZOA.
D004971 Estrus The period in the ESTROUS CYCLE associated with maximum sexual receptivity and fertility in non-primate female mammals.

Related Publications

M A Cukierski, and J L Sina, and S Prahalada, and L D Wise, and J M Antonello, and J S MacDonald, and R T Robertson
Reversible decreases of fertility in male Sprague-Dawley rats treated orally with finasteride, a 5 alpha-reductase inhibitor.
January 1991, Reproductive toxicology (Elmsford, N.Y.),
M A Cukierski, and J L Sina, and S Prahalada, and L D Wise, and J M Antonello, and J S MacDonald, and R T Robertson
External genitalia abnormalities in male rats exposed in utero to finasteride, a 5 alpha-reductase inhibitor.
July 1990, Teratology,
M A Cukierski, and J L Sina, and S Prahalada, and L D Wise, and J M Antonello, and J S MacDonald, and R T Robertson
Finasteride: a 5 alpha-reductase inhibitor.
January 1993, Clinical pharmacy,
M A Cukierski, and J L Sina, and S Prahalada, and L D Wise, and J M Antonello, and J S MacDonald, and R T Robertson
Finasteride: the first 5 alpha-reductase inhibitor.
January 1993, Pharmacotherapy,
M A Cukierski, and J L Sina, and S Prahalada, and L D Wise, and J M Antonello, and J S MacDonald, and R T Robertson
Finasteride: a slow-binding 5 alpha-reductase inhibitor.
June 1993, Biochemistry,
M A Cukierski, and J L Sina, and S Prahalada, and L D Wise, and J M Antonello, and J S MacDonald, and R T Robertson
Pharmacodynamic modeling of finasteride, a 5 alpha-reductase inhibitor.
January 1995, Pharmacotherapy,
M A Cukierski, and J L Sina, and S Prahalada, and L D Wise, and J M Antonello, and J S MacDonald, and R T Robertson
The clinical development of a 5 alpha-reductase inhibitor, finasteride.
November 1990, The Journal of steroid biochemistry and molecular biology,
M A Cukierski, and J L Sina, and S Prahalada, and L D Wise, and J M Antonello, and J S MacDonald, and R T Robertson
C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
March 1990, The Journal of clinical endocrinology and metabolism,
M A Cukierski, and J L Sina, and S Prahalada, and L D Wise, and J M Antonello, and J S MacDonald, and R T Robertson
Effects of finasteride (MK-906), a 5 alpha-reductase inhibitor, on circulating androgens in male volunteers.
April 1990, The Journal of clinical endocrinology and metabolism,
M A Cukierski, and J L Sina, and S Prahalada, and L D Wise, and J M Antonello, and J S MacDonald, and R T Robertson
Male pseudohermaphroditism presumably due to 5 alpha reductase deficiency.
April 1983, The Journal of the Association of Physicians of India,
Copied contents to your clipboard!